Exagen Reaches 1M Patient Tested Vy AVISE CTD Milestone

Benzinga12/12 22:02

Exagen Inc. Achieves Key Milestone With 1,000,000th Patient Tested by AVISE CTD

GlobeNewswire12/12 22:00

Life Sciences Stocks Viewed Positively at TD Cowen Despite Post-election Weakness

Seeking Alpha11/16 04:55

Exagen Inc. (NASDAQ:XGN) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Simply Wall St11/15 19:13

Exagen Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Yahoo Finance11/15 18:50

Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE CTD Platform

GlobeNewswire11/15 05:30